Pharmaceutical Firm Installs 9.95 MW Solar
KDC Solar commenced commercial operations of its 9.95- MW solar panel system in New Jersey. The system will provide electricity to Eli Lilly and Company’s ImClone biopharmaceutical operations in Branchburg, NJ.
The new system will generate nearly 12.9 million kWh per year. It will provide the primary Lilly manufacturing facility at this location with about 45 percent of its annual electricity needs. KDC Solar developed, owns and will operate the solar panel system.
KDC Solar signed an engineering and construction contract for the installation of the solar project with The Whiting-Turner Contracting Company and SPI Solar. Whiting-Turner was the general contractor, and SPI Solar provided solar panel procurement and oversight.
The solar panel system uses 40,180 PV panels, 16 Advanced Energy Industries 500 kilowatt inverters and is ground-mounted across 43 acres of land owned by a subsidiary of KDC Solar.
- 2015 Environmental Leader Product & Project Awards
- Enterprise Internet Of Things: What Is It, and How Will It Improve Energy Management?
- 10 Tactics of Successful Energy Managers
- Improve Your Company's Environment and Energy Performance
- Energy Manager Today Awards Top Products and Top Projects of the Year
- Practical Insights into the Implementation of GHS Around the Globe
- There’s Money in the Trash
- Beyond Compliance: Applying a Risk Lens to Your EHS Practice
- A Roadmap for Effective Process Safety Management
- NAEM 2015 EHS and Sustainability Software Buyers Guide